Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.
Press releases published on August 4, 2025
Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET
HOLLISTON, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2025, before the market opens on August 11, 2025, and will hold a conference call to discuss the …
Vodafone and Kaltura Sign a Long-Term Partnership Agreement to Expand Cloud TV Services
New York, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Vodafone Group PLC (Nasdaq: VOD) and Kaltura (Nasdaq: KLTR), the AI Video Experience Cloud, today announced that they have extended their partnership around the Kaltura-powered Vodafone TV solution (VTV). …
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
-CASGEVY® momentum building; >75 authorized treatment centers (ATCs) activated globally, achieving the target goal and ~115 patients have had cells collected across all regions; positioning the program for strong future growth- -Clinical trial ongoing for …
EverQuote Announces Second Quarter 2025 Financial Results
Second Quarter Revenue Growth of 34% Year-Over-Year to $156.6 million Second Quarter Variable Marketing Dollars Increase 25% Year-Over-Year to $45.5 million Delivers Second Quarter Record Net Income of $14.7 million and Adjusted EBITDA of $22.0 million …
Ardelyx Announces Changes to the Executive Leadership Team
Edward Conner, M.D. appointed Chief Medical Officer and John Bishop, Ph.D. appointed Chief Technical Operations Officer Justin Renz, Chief Financial and Operations Officer, to transition out of the Company WALTHAM, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- …
METAVSHN LLC and Ticinocom SA Collaborate to Launch ‘HCAP Connect’, a New MVNO and ISP Brand for Swiss Ice Hockey Fans
Muralto, Switzerland, Aug. 04, 2025 (GLOBE NEWSWIRE) -- METAVSHN LLC, a Swiss leader in advanced software platforms for Internet Service Providers (ISPs), has announced the launch of a new mobile virtual network operator (MVNO) brand, “HCAP Connect,” in …
ODDITY Tech Reports Record Second Quarter Results, Raises Full Year Outlook
Second quarter net revenue of $241 million, up 25% year-over-year Second quarter adjusted EBITDA of $70 million Second quarter net income of $49 million and second quarter adjusted net income of $57 million First half operating cash flow of $101 million …
Vimeo Q2 2025 Shareholder Letter Available on Company's IR Site
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Vimeo posted its second quarter 2025 shareholder letter on the investor relations section of its website at https://www.vimeo.com/investors. Vimeo will live stream a video conference to answer questions regarding …
Crane NXT to Participate in the Oppenheimer 28th Annual Technology, Internet & Communications Conference
WALTHAM, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT), a premier industrial technology company, announced that Aaron Saak, President and Chief Executive Officer, and Christina Cristiano, Senior Vice President and Chief Financial …
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
FOSTER CITY, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases …
Tactile Systems Technology, Inc. Reports Second Quarter 2025 Financial Results
MINNEAPOLIS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the …
Mineralys Therapeutics to Announce Second Quarter 2025 Financial Results and Host Conference Call on Tuesday, August 12, 2025
RADNOR, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as hypertensive nephropathy, …
iMDx to Release Second Quarter 2025 Results on August 11, 2025 and Attend Needham Virtual MedTech and Diagnostics Conference
NASHVILLE, Tenn., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics, or iMDx, (Nasdaq: IMDX), today announced that it will report second quarter 2025 financial results after the market closes on Monday, August 11, 2025. iMDx will host a live …
HEO and Satellogic Expand Agreement with Exclusive Access to Non-Earth Imagery for Space Domain Awareness
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Satellogic, Inc. (NASDAQ: SATL), a leader in satellite manufacturing and high-resolution Earth observation data, today announced an expanded agreement with HEO, the world’s leading commercial provider of non- …
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …
FibroGen to Report Second Quarter 2025 Financial Results
SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce second quarter 2025 financial results on Monday, August 11 after the markets close. FibroGen will also conduct a conference call on that day at 5:00 PM Eastern …
Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update
Company reports strong commercial performance in the second quarter, recording $97.7 million in total revenue, reflecting 33% growth year-over-year IBSRELA generated net sales revenue of $65.0 million; XPHOZAH generated net sales revenue of $25.0 million …
Syndax Reports Second Quarter 2025 Financial Results and Provides Business Update
– $28.6 million of Revuforj® (revumenib) net revenue, representing 43% growth over 1Q25 – – $36.2 million of Niktimvo™ (axatilimab-csfr) net revenue reported by Incyte in first full quarter of launch; $9.4 million in collaboration revenue reported by …
Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia
First regulatory approval for PYRUKYND in thalassemia, evaluated under SFDA’s Breakthrough Medicines Program Agios partnered with NewBridge Pharmaceuticals, a regional specialty company focused on the Middle East and North Africa, in 2024 to manage …
PolTREG Doses First Patient in Phase II Trial for Pre-Symptomatic Type 1 Diabetes with PTG-007
PolTREG Doses First Patient in Phase II Trial for Pre-Symptomatic Type 1 Diabetes with PTG-007 PTG-007, an autologous cell therapy will be administered to 150 high-risk children aged 3–18, including a placebo-controlled arm. A parallel study presented to …